Qing-Rong Tan

Qing-Rong Tan

Auto-generated profile, based on publicly available information

Qing-Rong Tan

Department of Psychosomatic Medicine, Xijing Hospital, Fourth Military Medical University. Xi'an 710032, China

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
ZZZhang-Jin Zhang
Zhang-Jin Zhang
DWDi Wang
Di Wang
SMSui Cheung Man
Sui Cheung Man
RNRoger Ng
Roger Ng
GMGrainne M. McAlonan
Grainne M. McAlonan
QTQing-rong Tan
Qing-rong Tan

19 December 2018 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Open access
PDF file
BFBin Feng
Bin Feng
YZYing Zhang
Ying Zhang
LLLiyuan Luo
Liyuan Luo
Jian-Yong WuJian-Yong Wu
Jian-Yong Wu
SYSen‐Jun Yang
Sen‐Jun Yang
ZZZhang-Jin Zhang
Zhang-Jin Zhang
Aim: Transcutaneous electrical acupoint stimulation (TEAS) has the potential to alleviate post‐traumatic stress disorder (PTSD). The purpose of this study was to determine whether adding TEAS to sertraline or cognitive behavioral therapy (CBT) could improve the anti‐PTSD efficacy.Methods: In this randomized controlled trial, 240 PTSD patients (60 in each group) were assigned to receive simulated TEAS combined with sertraline (group A) or with CBT (group B), active TEAS combined with CBT (group C), or active TEAS combined with CBT plus sertraline (group D) for 12 weeks. The outcomes were measured using the Clinician‐Administered PTSD Scale, PTSD Check List‐Civilian Version, and 17‐item Hamilton Rating Scale for Depression.Results: While PTSD symptoms reduced over time in all patients, groups C and D had markedly greater improvement in both PTSD and depressive measures than groups A and B in all post‐baseline measurement points, with moderate to very large effect sizes of 0.484–2.244. Groups C and D also had a significantly higher rate than groups A and B on clinical response (85.0% and 95.0% vs 63.3% and 60.0%, P < 0.001) and on remission (15.0% and 25.0% vs 3.3% and 1.7%, P < 0.001). The incidence of adverse events was similar between groups A and D and between groups B and C.Conclusions: Additional TEAS augments the anti‐PTSD and antidepressant efficacy of antidepressants or CBT, without increasing the incidence of adverse effects. TEAS could serve as an effective intervention for PTSD and comorbid depression. This trial was registered with www.chictr.org (no.: ChiCTR1800017255).

25 September 2017 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Zhengwu PengZhengwu Peng
Zhengwu Peng
FXFen Xue
Fen Xue
CZcuihong zhou
cuihong zhou
RZRuiguo Zhang
Ruiguo Zhang
YWYing Wang
Ying Wang
QTQing-rong Tan
Qing-rong Tan


1 July 2008 in Journal of Affective Disorders
Verified
Journal Article
Closed access
ZZZhang-Jin Zhang
Zhang-Jin Zhang
QTQing-rong Tan
Qing-rong Tan
YTYao Tong
Yao Tong
QLQiang Li
Qiang Li
WKWan-Hu Kang
Wan-Hu Kang
RPRobert M. Post
Robert M. Post

1 January 2015 in Journal of Affective Disorders
Verified
Journal Article
Closed access
LLLanying Liu
Lanying Liu
BFBin Feng
Bin Feng
Jiong ChenJiong Chen
Jiong Chen
QTQing-rong Tan
Qing-rong Tan
ZCZheng-Xin Chen
Zheng-Xin Chen
ZZZhang-Jin Zhang
Zhang-Jin Zhang